UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients

Breast care (Basel, Switzerland), 2016-02, Vol.11 (1), p.8-12

Möbus, Volker

2016

Volltextzugriff (PDF)

Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (“METRIC”): a randomized multicenter study

NPJ breast cancer, 2021-05, Vol.7 (1), p.57-57, Article 57

2021

Volltextzugriff (PDF)

Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2016-11, Vol.316 (18), p.1888

2016

Volltextzugriff (PDF)

German Adjuvant Intergroup Node-Positive Study: A Phase III Trial to Compare Oral Ibandronate Versus Observation in Patients With High-Risk Early Breast Cancer

Journal of clinical oncology, 2013-10, Vol.31 (28), p.3531-3539

2013

Volltextzugriff (PDF)

Characteristics and Clinical Outcome of Breast Cancer Patients with Asymptomatic Brain Metastases

Cancers, 2020-10, Vol.12 (10), p.2787

2020

Volltextzugriff (PDF)

Intensive Dose-Dense Compared With Conventionally Scheduled Preoperative Chemotherapy for High-Risk Primary Breast Cancer

Journal of clinical oncology, 2009-06, Vol.27 (18), p.2938-2945

2009

Volltextzugriff (PDF)

TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer

BMC cancer, 2021-08, Vol.21 (1), p.1-920, Article 920

2021

Volltextzugriff (PDF)

Randomized Phase III Trial of Topotecan Following Carboplatin and Paclitaxel in First-line Treatment of Advanced Ovarian Cancer: A Gynecologic Cancer Intergroup Trial of the AGO-OVAR and GINECO

JNCI : Journal of the National Cancer Institute, 2006-08, Vol.98 (15), p.1036-1045

2006

Volltextzugriff (PDF)

Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry-Comparison of Three Different GPA Prognostic Scores

Cancers, 2021-02, Vol.13 (4), p.844

2021

Volltextzugriff (PDF)

Radiological Patterns of Brain Metastases in Breast Cancer Patients: A Subproject of the German Brain Metastases in Breast Cancer (BMBC) Registry

International journal of molecular sciences, 2016-10, Vol.17 (10), p.1615-1615

2016

Volltextzugriff (PDF)

Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer

BMC cancer, 2021-09, Vol.21 (1), p.1-1024, Article 1024

2021

Volltextzugriff (PDF)

The role of cervical cultures to guide perioperative antibiotics in cervical cerclage - a retrospective analysis of 65 consecutive cases

The journal of maternal-fetal & neonatal medicine, 2016-11, Vol.29 (22), p.3629-3633

2016

Volltextzugriff (PDF)

GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer

NPJ breast cancer, 2024-07, Vol.10 (1), p.66-10, Article 66

2024

Volltextzugriff (PDF)

Breast Cancer Outcome: What Have We Achieved

Breast care (Basel, Switzerland), 2023-12, Vol.18 (6), p.419-421

2023

Volltextzugriff (PDF)

Phase III Trial of High-Dose Sequential Chemotherapy With Peripheral Blood Stem Cell Support Compared With Standard Dose Chemotherapy for First-Line Treatment of Advanced Ovarian Cancer: Intergroup Trial of the AGO-Ovar/AIO and EBMT

Journal of clinical oncology, 2007-09, Vol.25 (27), p.4187-4193

2007

Volltextzugriff (PDF)

Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer

Breast cancer research and treatment, 2020-05, Vol.181 (1), p.87-96

2020

Volltextzugriff (PDF)

HER-2/neu Gene Amplification and Response to Paclitaxel in Patients With Metastatic Breast Cancer

JNCI : Journal of the National Cancer Institute, 2004-08, Vol.96 (15), p.1141-1151

2004

Volltextzugriff (PDF)

Onkologie. ETC-Regime: Hilfe für Hochrisikopatientinnen mit Mammakarzinom

Geburtshilfe und Frauenheilkunde, 2012-05, Vol.72 (5), p.367-369

Möbus, Volker

2012

Volltextzugriff (PDF)

If Chemotherapy Is Indicated, Give the Optimal Regimen

Breast care (Basel, Switzerland), 2016-02, Vol.11 (1), p.6-7

Möbus, Volker

2016

Volltextzugriff (PDF)

Assessing the Clinical Benefit of Systemic Adjuvant Therapies for Early Breast Cancer

Geburtshilfe und Frauenheilkunde, 2017-10, Vol.77 (10), p.1079-1087

2017

Volltextzugriff (PDF)

Bestimmung des klinischen Nutzens systemischer adjuvanter Therapien beim frühen Mammakarzinom

Senologie (Stuttgart), 2018-12, Vol.15 (4), p.219-228

2018

Volltextzugriff (PDF)

1 – 25 von 120

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(100)

Publikationsform

Artikel
(116)
Buchkapitel
(4)

Sprache

Englisch
(108)
Deutsch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(80)
Life Sciences & Biomedicine
(79)
Oncology
(66)
Humans
(51)
Female
(50)
Breast Cancer
(39)
Middle Aged
(34)
Aged
(30)
Obstetrics & Gynecology
(30)
Adult
(28)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Tumors
(24)
Chemotherapy
(20)
Breast Neoplasms - Drug Therapy
(18)
Breast Neoplasms - Pathology
(16)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(15)
Disease-Free Survival
(15)
Gynecology. Andrology. Obstetrics
(15)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients

Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (“METRIC”): a randomized multicenter study

Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial

German Adjuvant Intergroup Node-Positive Study: A Phase III Trial to Compare Oral Ibandronate Versus Observation in Patients With High-Risk Early Breast Cancer

Characteristics and Clinical Outcome of Breast Cancer Patients with Asymptomatic Brain Metastases

Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference - Substudy of the randomised phase III GAIN-2 study

Intensive Dose-Dense Compared With Conventionally Scheduled Preoperative Chemotherapy for High-Risk Primary Breast Cancer

TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer

Randomized Phase III Trial of Topotecan Following Carboplatin and Paclitaxel in First-line Treatment of Advanced Ovarian Cancer: A Gynecologic Cancer Intergroup Trial of the AGO-OVAR and GINECO

Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry-Comparison of Three Different GPA Prognostic Scores

Radiological Patterns of Brain Metastases in Breast Cancer Patients: A Subproject of the German Brain Metastases in Breast Cancer (BMBC) Registry

Pathological Response in the Breast and Axillary Lymph Nodes after Neoadjuvant Systemic Treatment in Patients with Initially Node-Positive Breast Cancer Correlates with Disease Free Survival: An Exploratory Analysis of the GeparOcto Trial

Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer

Efficacy of Endocrine Therapy for the Treatment of Breast Cancer in Men: Results from the MALE Phase 2 Randomized Clinical Trial

The role of cervical cultures to guide perioperative antibiotics in cervical cerclage - a retrospective analysis of 65 consecutive cases

GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer

Breast Cancer Outcome: What Have We Achieved

13th St. Gallen International Breast Cancer Conference 2013: Primary Therapy of Early Breast Cancer Evidence, Controversies, Consensus - Opinion of a German Team of Experts (Zurich 2013)

Phase III Trial of High-Dose Sequential Chemotherapy With Peripheral Blood Stem Cell Support Compared With Standard Dose Chemotherapy for First-Line Treatment of Advanced Ovarian Cancer: Intergroup Trial of the AGO-Ovar/AIO and EBMT

Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer

HER-2/neu Gene Amplification and Response to Paclitaxel in Patients With Metastatic Breast Cancer

Onkologie. ETC-Regime: Hilfe für Hochrisikopatientinnen mit Mammakarzinom

If Chemotherapy Is Indicated, Give the Optimal Regimen

Assessing the Clinical Benefit of Systemic Adjuvant Therapies for Early Breast Cancer

Bestimmung des klinischen Nutzens systemischer adjuvanter Therapien beim frühen Mammakarzinom

Suchergebnisse filtern